She currently leads several large epidemiologic studies focusing on the role of pre and postnatal factors on breast cancer risk. She also focuses on molecular epidemiology and gene environment interactions. She is a National Cancer Institute recipient of a 5-year R01 grant to study the relationship between early life factors and breast cancer and has related research on the role of epigenetics and breast cancer risk. Dr. Terry is also the PI of the New York Metropolitan Breast Cancer Registry which is a family registry of high risk women with and without breast cancer. Dr. Terry recently completed an NCI K07 Career Development Award and an American Cancer Society Clinical Training Award.